![Alkaloids / Benzoates / Carbamates / Docetaxel / Microbicides for sexually transmitted diseases / Dendrimer / Prostate cancer / Clinical trial / Australian Securities Exchange / Chemistry / Medicine / Health Alkaloids / Benzoates / Carbamates / Docetaxel / Microbicides for sexually transmitted diseases / Dendrimer / Prostate cancer / Clinical trial / Australian Securities Exchange / Chemistry / Medicine / Health](https://www.pdfsearch.io/img/9ddc11d930b0c8431c8b1e34376e521b.jpg) Date: 2014-03-10 23:11:49Alkaloids Benzoates Carbamates Docetaxel Microbicides for sexually transmitted diseases Dendrimer Prostate cancer Clinical trial Australian Securities Exchange Chemistry Medicine Health | | Starpharma receives $4.7M R&D tax incentive Melbourne, Australia; 11 March 2014: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced it has received the anticipated $4.7M of R&D tax incentive relating to FY13 expenditureAdd to Reading ListSource URL: www.starpharma.comDownload Document from Source Website File Size: 335,41 KBShare Document on Facebook
|